DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Though 23andMe says the restructuring plan will cost it around $12 million, it expects to save more than $35 million as a ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

23andMe posted a narrower loss in its fiscal second quarter, the day after announcing it would cut 40% of its workforce and discontinue its pipeline of therapeutics.

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as ...

23andMe is shutting down its therapeutics development division and plans to seek out buyers to find a new home for its ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...

23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...

Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing ...